Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shilai Tian
Hepatoma‑derived Growth Factor Functions as an Unfavorable Prognostic Marker of Human Gliomas
Oncology Letters
Cancer Research
Oncology
Related publications
Hepatoma-Derived Growth Factor Upregulation Is Correlated With Prognostic Factors of Early-Stage Cervical Adenocarcinoma
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Hepatoma-Derived Growth Factor and Its Role in Keloid Pathogenesis
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Stromal Micropapillary Component as a Novel Unfavorable Prognostic Factor of Lung Adenocarcinoma
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Hepatoma-Derived Growth Factor Is a Pulmonary Endothelial Cell-Expressed Angiogenic Factor
American Journal of Physiology - Lung Cellular and Molecular Physiology
Pulmonary
Respiratory Medicine
Physiology
Cell Biology
ING4 Suppresses Tumor Angiogenesis and Functions as a Prognostic Marker in Human Colorectal Cancer
Oncotarget
Oncology
Glucocorticoid Dependency as a Prognostic Factor in Radiotherapy for Cerebral Gliomas
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
Technology in Cancer Research and Treatment
Medicine
Cancer Research
Oncology
Up-Regulation of Hepatoma-Derived Growth Factor Facilities Tumor Progression in Malignant Melanoma
PLoS ONE
Multidisciplinary
Hepatoma-Derived Growth Factor Stimulates Smooth Muscle Cell Growth and Is Expressed in Vascular Development
Journal of Clinical Investigation
Medicine
